Clinical Trials Directory

Trials / Completed

CompletedNCT03766217

Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Hospital Sirio-Libanes · Academic / Other
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Accepted

Summary

Iliac crest autogenous bone graft is accepted as the most effective method for secondary alveolar cleft repair. However this method is associated with complications. As an alternative, mesenchymal stem cells associated with biomaterials have been used for the rehabilitation of the alveolar bone cleft of patients with cleft lip and palate. This is a RCT comparing mesenchymal stem cells obtained from autogenous deciduous dental pulp associated with biomaterials versus iliac crest autogenous bone graft for secondary alveolar cleft repair.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTMesenchymal stem cells associated with biomaterialsDeciduous dental pulp mesenchymal stem cells associated with hydroxyapatita/collagen.
COMBINATION_PRODUCTIliac crest autogenous bone graftAutogenous bone will be obtained from iliac crest.

Timeline

Start date
2019-04-05
Primary completion
2019-12-06
Completion
2019-12-15
First posted
2018-12-06
Last updated
2020-05-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03766217. Inclusion in this directory is not an endorsement.

Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair (NCT03766217) · Clinical Trials Directory